|BBC -- USA Etf|| |
USD 33.78 0.30 0.88%
Virtus LifeSci Biotech Clinical Trls ETF is rated below average
in price to book as compared to similar ETFs. It is second
largest ETF in price to earning as compared to similar ETFs reporting about 22.78
of Price to Earning per Price to Book.
July 22, 2018
Virtus LifeSci is not too volatile
asset. Calculation of real value of Virtus LifeSci Biotech is based on 1 month time horizon. Increasing Virtus LifeSci Biotech time horizon generally increases accuracy of value calculation and significantly improves predictive power of the methodology used.